Library
Celyad Reports Half Year 2019 Financial Results and Second Quarter Business Highlights
Celyad to Provide First Half 2019 Financial Results & Business Highlights and Host a Conference Call
Celyad to Provide First Half 2019 Financial Results & Business Highlights and Host a Conference Call
Phase 1 studies assessing the safety and clinical activity of autologous and allogeneic NKG2D-based CAR T therapy in metastatic colorectal cancer
Phase 1 studies assessing the safety and clinical activity of autologous and allogeneic NKG2D-based CAR T therapy in metastatic colorectal cancer
Celyad Presents Update on Autologous & Allogeneic NKG2D-based CAR-T Therapies in Solid Tumors
Celyad Presents Update on Autologous & Allogeneic NKG2D-based CAR-T Therapies in Solid Tumors
Celyad to Host Conference Call to Review Clinical Update from ESMO 21st World GI Congress
Celyad to Host Conference Call to Review Clinical Update from ESMO 21st World GI Congress
Celyad Announces Strategic Updates to the Autologous r/r AML and MDS Program
Celyad Announces Strategic Updates to the Autologous r/r AML and MDS Program
Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology Association
Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology Association
Modeling NKG2D-based CAR-T cell therapy in animals with acute myeloid leukemia
Modeling NKG2D-based CAR-T cell therapy in animals with acute myeloid leukemia
Updated results from Phase I trials assessing a NKG2D CAR T-cell approach in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome patients
Updated results from Phase I trials assessing a NKG2D CAR T-cell approach in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome patients
Development of a next generation allogeneic CAR-T cell platform without gene editing
Development of a next generation allogeneic CAR-T cell platform without gene editing
Celyad to Participate in Upcoming June 2019 Conferences
Celyad to Participate in Upcoming June 2019 Conferences
Celyad to Present Data at 24th Congress of the European Hematology Association
Celyad to Present Data at 24th Congress of the European Hematology Association